CoChat

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in Mice

Open access

Abstract

With obesity and type 2 diabetes (T2D) at epidemic levels, we need to understand the complex nature of these diseases to design better therapeutics. The underlying causes of both obesity and T2D are complex, but both are thought to develop, in part, based on contributions from the gut microbiota.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/msystems.00230-21

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Dietary NR supplementation deflects HFD-induced weight gain. (A) Six-week-old male C57BL/6J mice were placed on a high-fat diet (HFD) when they arrived and were on a baseline period for 2 weeks. Mice were weight matched, randomized, and divided into groups. NR-treated mice were supplemented with 0.4% NR, whereas for the control group, the diet was mixed with water (vehicle). Mice were housed in metabolic cages (M) during baseline and at the end of the experiment. Feces were collected for shotgun metagenomic sequencing at day 168. (B) NR-treated mice (red, n = 8) exhibited a statistically significant reduction in weight gain compared to control mice (cyan, n = 8). Data were analyzed by two-way ANOVA (*, P < 0.05). (C) After 168 days of NR treatment, there was a weight gain difference of 4.9 g between treatment groups. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). (D) At day 0, no statistically significant differences in body mass were found between groups, but after 168 days of treatment, there was a significant reduction in body mass in NR-treaded mice relative to control mice. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). All data are represented as the mean ± SEM.
FIG 1 Dietary NR supplementation deflects HFD-induced weight gain. (A) Six-week-old male C57BL/6J mice were placed on a high-fat diet (HFD) when they arrived and were on a baseline period for 2 weeks. Mice were weight matched, randomized, and divided into groups. NR-treated mice were supplemented with 0.4% NR, whereas for the control group, the diet was mixed with water (vehicle). Mice were housed in metabolic cages (M) during baseline and at the end of the experiment. Feces were collected for shotgun metagenomic sequencing at day 168. (B) NR-treated mice (red, n = 8) exhibited a statistically significant reduction in weight gain compared to control mice (cyan, n = 8). Data were analyzed by two-way ANOVA (*, P < 0.05). (C) After 168 days of NR treatment, there was a weight gain difference of 4.9 g between treatment groups. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). (D) At day 0, no statistically significant differences in body mass were found between groups, but after 168 days of treatment, there was a significant reduction in body mass in NR-treaded mice relative to control mice. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). All data are represented as the mean ± SEM.CC BY · PubMed Central
FIG 2 NR supplementation alters the gut microbiota compositional and functional profiles. To study the gut microbiota composition, feces from NR-treated (n = 6) and control (n = 6) mice were collected and subjected to shotgun metagenomic sequencing. (A) Principal-coordinate analysis (PCoA) plot of Bray-Curtis distances illustrating differences in the gut microbiome between treatment groups at day 168. By implementing shotgun metagenomic sequencing, we found that NR-treated mice (red) exhibited a unique gut microbiome (PERMANOVA; *, P < 0.05) compared to control mice (cyan). (B) Anvi’o plot illustrating the relative abundance of 14 discriminatory MAGs identified by linear discriminant analysis effect size (LEfSe). The LEfSe analysis was performed using all 88 MAGs. MAGs are ordered by phylogenetic tree. Taxon names highlighted in cyan represent MAGs enriched in control mice, whereas the taxon names highlighted in red were found enriched in NR mice. The majority of MAGs belong to the Firmicutes phylum, whereas the MAGs Unknown_Burkholderiales and Atopobium belong to Proteobacteria and Actinobacteria, respectively. (C) Fecal SCFA concentrations. NR-treated mice exhibited a significant increase in fecal propionate, butyrate, valerate, and isobutyrate compared to control mice. All values were normalized by milligram of feces. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). All data are represented as the mean ± SEM. (D) Discriminant KEGG pathways enriched in NR-treated mice and control mice. The Q2Q3 coverage (defined by anvi’o as the average depth of coverage excluding nucleotide positions with coverages in the 1st and 4th quartiles) of KEGG pathways was analyzed using LEfSe. The significant LDA scores are colored cyan for the control group, whereas the scores for the NR-treated mice are colored red. (E) Network visualization of discriminant KOs enriched in NR-treated and control mice. We performed LEfSe on all KOs from enriched pathways and found 90 discriminant KOs. The network was visualized and annotated in Cytoscape. Node size represents LDA scores from discriminant KOs, whereas the edge width represents r values calculated from Pearson correlations (0.8 cutoff). The compound spring embedded (CoSE) layout was applied to the network.
FIG 2 NR supplementation alters the gut microbiota compositional and functional profiles. To study the gut microbiota composition, feces from NR-treated (n = 6) and control (n = 6) mice were collected and subjected to shotgun metagenomic sequencing. (A) Principal-coordinate analysis (PCoA) plot of Bray-Curtis distances illustrating differences in the gut microbiome between treatment groups at day 168. By implementing shotgun metagenomic sequencing, we found that NR-treated mice (red) exhibited a unique gut microbiome (PERMANOVA; *, P < 0.05) compared to control mice (cyan). (B) Anvi’o plot illustrating the relative abundance of 14 discriminatory MAGs identified by linear discriminant analysis effect size (LEfSe). The LEfSe analysis was performed using all 88 MAGs. MAGs are ordered by phylogenetic tree. Taxon names highlighted in cyan represent MAGs enriched in control mice, whereas the taxon names highlighted in red were found enriched in NR mice. The majority of MAGs belong to the Firmicutes phylum, whereas the MAGs Unknown_Burkholderiales and Atopobium belong to Proteobacteria and Actinobacteria, respectively. (C) Fecal SCFA concentrations. NR-treated mice exhibited a significant increase in fecal propionate, butyrate, valerate, and isobutyrate compared to control mice. All values were normalized by milligram of feces. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). All data are represented as the mean ± SEM. (D) Discriminant KEGG pathways enriched in NR-treated mice and control mice. The Q2Q3 coverage (defined by anvi’o as the average depth of coverage excluding nucleotide positions with coverages in the 1st and 4th quartiles) of KEGG pathways was analyzed using LEfSe. The significant LDA scores are colored cyan for the control group, whereas the scores for the NR-treated mice are colored red. (E) Network visualization of discriminant KOs enriched in NR-treated and control mice. We performed LEfSe on all KOs from enriched pathways and found 90 discriminant KOs. The network was visualized and annotated in Cytoscape. Node size represents LDA scores from discriminant KOs, whereas the edge width represents r values calculated from Pearson correlations (0.8 cutoff). The compound spring embedded (CoSE) layout was applied to the network.CC BY · PubMed Central
FIG 3 NR-conditioned fecal material transfer reduces HFD-induced weight gain. (A) Six-week-old male C57BL/6J mice fed a 60% HFD were on a baseline period for 3 weeks. Mice were weight matched, randomized, and divided into groups. Mice received 0.1 g feces/mL PBS from either NR-treated or control donors daily via oral gavage. Mice were housed in metabolic cages (M) during baseline and at the end of the experiment. Feces were collected for shotgun metagenomic sequencing at day 35. (B) Naive mice treated daily with feces from NR-treated donors (FMT-NR, red, n = 9) exhibited a reduction in weight gain relative to naive mice receiving feces from control donors (FMT-control, cyan, n = 9). Data were analyzed by two-way ANOVA (*, P < 0.05). (C) At day 35, there was a weight gain difference of 2.2 g between groups. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). (D) At day 0, no statistically significant differences in body mass were found between groups. After 35 days of FMT-NR treatment, there was a significant reduction in body mass relative to that of the control. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). All data are represented as the mean ± SEM.
FIG 3 NR-conditioned fecal material transfer reduces HFD-induced weight gain. (A) Six-week-old male C57BL/6J mice fed a 60% HFD were on a baseline period for 3 weeks. Mice were weight matched, randomized, and divided into groups. Mice received 0.1 g feces/mL PBS from either NR-treated or control donors daily via oral gavage. Mice were housed in metabolic cages (M) during baseline and at the end of the experiment. Feces were collected for shotgun metagenomic sequencing at day 35. (B) Naive mice treated daily with feces from NR-treated donors (FMT-NR, red, n = 9) exhibited a reduction in weight gain relative to naive mice receiving feces from control donors (FMT-control, cyan, n = 9). Data were analyzed by two-way ANOVA (*, P < 0.05). (C) At day 35, there was a weight gain difference of 2.2 g between groups. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). (D) At day 0, no statistically significant differences in body mass were found between groups. After 35 days of FMT-NR treatment, there was a significant reduction in body mass relative to that of the control. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05). All data are represented as the mean ± SEM.CC BY · PubMed Central
FIG 4 NR-conditioned fecal material transfer remodels the gut microbiome similarly to NR supplementation. (A) Principal-coordinate analysis (PCoA) plot of Bray-Curtis distances illustrating differences in the gut microbiome at day 35 from shotgun metagenomic sequencing. By implementing shotgun metagenomic sequencing, we found that FMT-NR-treated mice (red) exhibited a unique gut microbiome (PERMANOVA; *, P < 0.05) in comparison to FMT-control mice (cyan). (B) Anvi’o plot illustrating the relative abundance of 21 discriminatory MAGs identified by LEfSe. The analysis was performed using all 78 MAGs. MAGs are ordered by phylogenetic tree. Taxon names highlighted in cyan represent MAGs enriched in FMT-control mice, whereas the taxon names highlighted in red were found enriched in FMT-NR mice. The majority of MAGs belong to the Firmicutes phylum, whereas the Burkholderiales MAG belongs to the Proteobacteria phylum. (C) Fecal SCFA concentrations. No significant differences between FMT-NR-treated and FMT-control mice were found in fecal propionate, butyrate, valerate, and isobutyrate. All values were normalized by milligram of feces. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05; ns, nonsignificant). All data are represented as the mean ± SEM. (D) Discriminant KEGG pathways enriched in FMT-NR-treated mice and FMT-control mice. The Q2Q3 coverage of KEGG pathways was analyzed by LEfSe. The significant LDA scores are shown in cyan for pathways enriched in the FMT-control mice, whereas the pathways enriched in FMT-NR mice are shown red. (E) Network visualization of KOs enriched in FMT-NR-treated and FMT-control mice. We performed LEfSe on all KOs from discriminant pathways and found 72 discriminant KOs. The network was visualized and annotated in Cytoscape. The node size represents LDA scores from discriminant KOs, whereas the edge width represents r values calculated from Pearson correlations (0.7 cutoff). The compound spring embedded (CoSE) layout was applied to the network.
FIG 4 NR-conditioned fecal material transfer remodels the gut microbiome similarly to NR supplementation. (A) Principal-coordinate analysis (PCoA) plot of Bray-Curtis distances illustrating differences in the gut microbiome at day 35 from shotgun metagenomic sequencing. By implementing shotgun metagenomic sequencing, we found that FMT-NR-treated mice (red) exhibited a unique gut microbiome (PERMANOVA; *, P < 0.05) in comparison to FMT-control mice (cyan). (B) Anvi’o plot illustrating the relative abundance of 21 discriminatory MAGs identified by LEfSe. The analysis was performed using all 78 MAGs. MAGs are ordered by phylogenetic tree. Taxon names highlighted in cyan represent MAGs enriched in FMT-control mice, whereas the taxon names highlighted in red were found enriched in FMT-NR mice. The majority of MAGs belong to the Firmicutes phylum, whereas the Burkholderiales MAG belongs to the Proteobacteria phylum. (C) Fecal SCFA concentrations. No significant differences between FMT-NR-treated and FMT-control mice were found in fecal propionate, butyrate, valerate, and isobutyrate. All values were normalized by milligram of feces. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05; ns, nonsignificant). All data are represented as the mean ± SEM. (D) Discriminant KEGG pathways enriched in FMT-NR-treated mice and FMT-control mice. The Q2Q3 coverage of KEGG pathways was analyzed by LEfSe. The significant LDA scores are shown in cyan for pathways enriched in the FMT-control mice, whereas the pathways enriched in FMT-NR mice are shown red. (E) Network visualization of KOs enriched in FMT-NR-treated and FMT-control mice. We performed LEfSe on all KOs from discriminant pathways and found 72 discriminant KOs. The network was visualized and annotated in Cytoscape. The node size represents LDA scores from discriminant KOs, whereas the edge width represents r values calculated from Pearson correlations (0.7 cutoff). The compound spring embedded (CoSE) layout was applied to the network.CC BY · PubMed Central
FIG 5 NR supplementation decreases energy efficiency in HFD-fed mice. To understand the underlying mechanism of weight gain, mice were housed in metabolic cages to quantitatively assess food and water intake and urine and fecal output. Feces were subjected to bomb calorimetry. No significant differences between treatment groups were found in food consumption (A), energy absorbed (B), or digestive efficiency (C). (D) NR-treated mice exhibited a decrease in energy efficiency compared to control mice (P value = 0.05). All data are represented as the mean ± SEM. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05).
FIG 5 NR supplementation decreases energy efficiency in HFD-fed mice. To understand the underlying mechanism of weight gain, mice were housed in metabolic cages to quantitatively assess food and water intake and urine and fecal output. Feces were subjected to bomb calorimetry. No significant differences between treatment groups were found in food consumption (A), energy absorbed (B), or digestive efficiency (C). (D) NR-treated mice exhibited a decrease in energy efficiency compared to control mice (P value = 0.05). All data are represented as the mean ± SEM. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05).CC BY · PubMed Central
FIG 6 NR-conditioned fecal material transfer decreases energy efficiency. To understand the underlying mechanism of weight gain, mice were housed in metabolic cages and feces were subjected to bomb calorimetry. No significant differences between treatment groups were found in food consumption (A), energy absorbed (B), or digestive efficiency (C). (D) FMT-NR-treated mice (red) exhibited a statistically significant decrease in energy efficiency compared to FMT-control mice (cyan). This suggests that the reduction in weight gain is likely due to an increase in energy expenditure. Data are represented as the mean ± SEM. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05).
FIG 6 NR-conditioned fecal material transfer decreases energy efficiency. To understand the underlying mechanism of weight gain, mice were housed in metabolic cages and feces were subjected to bomb calorimetry. No significant differences between treatment groups were found in food consumption (A), energy absorbed (B), or digestive efficiency (C). (D) FMT-NR-treated mice (red) exhibited a statistically significant decrease in energy efficiency compared to FMT-control mice (cyan). This suggests that the reduction in weight gain is likely due to an increase in energy expenditure. Data are represented as the mean ± SEM. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05).CC BY · PubMed Central
FIG 7 NR-conditioned fecal material transfer alters NAD+/NADH ratios in the cecum. (A) Mouse ceca were harvested, flash-frozen in liquid nitrogen, and stored at −80°C until processed. Cecal contents were separated from the tissue, and these were processed separately. Samples were equally split in half. To extract NAD+ and NADH metabolites, acidic and basic extractions were performed, respectively, from both the cecal tissue and the cecal contents. (B) FMT-NR-treated mice (red squares) and FMT-control mice (cyan squares) exhibited similar NAD+ levels in the cecal tissue. FMT-NR- treated mice (red squares) and FMT-control mice (cyan squares) exhibited similar NADH levels in the cecal tissue. (C) FMT-NR-treated mice (red squares) and FMT-control mice (cyan squares) exhibited similar NAD+ levels in the cecal contents. FMT-NR-treated mice (red squares) exhibited a significant increase in NADH levels in the cecal contents compared to FMT-control mice (cyan squares). Data are represented as the mean ± SEM. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05).
FIG 7 NR-conditioned fecal material transfer alters NAD+/NADH ratios in the cecum. (A) Mouse ceca were harvested, flash-frozen in liquid nitrogen, and stored at −80°C until processed. Cecal contents were separated from the tissue, and these were processed separately. Samples were equally split in half. To extract NAD+ and NADH metabolites, acidic and basic extractions were performed, respectively, from both the cecal tissue and the cecal contents. (B) FMT-NR-treated mice (red squares) and FMT-control mice (cyan squares) exhibited similar NAD+ levels in the cecal tissue. FMT-NR- treated mice (red squares) and FMT-control mice (cyan squares) exhibited similar NADH levels in the cecal tissue. (C) FMT-NR-treated mice (red squares) and FMT-control mice (cyan squares) exhibited similar NAD+ levels in the cecal contents. FMT-NR-treated mice (red squares) exhibited a significant increase in NADH levels in the cecal contents compared to FMT-control mice (cyan squares). Data are represented as the mean ± SEM. Data were analyzed by an unpaired t test with Welch’s correction (*, P < 0.05).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Research works printed but not linked: 1

  1. Garrow JS, Webster J. 1985. Quetelet’s index (W/H2) as a measure of fatness. Int J Obes 9:147–153.

Cited by

See all 23

Metadata

Authors
Lozada-Fernández, V. V., deLeon, O., Kellogg, S. L., Saravia, F. L., Hadiono, M. A., Atkinson, S. N., Grobe, J. L., & Kirby, J. R.
Affiliations
  • Medical College of Wisconsin (US)
  • University of Chicago (US)
Corresponding author
Kirby, John R.
Venue
mSystems
Published
2022-02-22
Volume
7
Issue
1
Pages
e0023021-e0023021
ISSN
2379-5077 (ISSN-L)
OpenAlex
W4206987838
Cited by
23
References
80
Citations by year
2026: 3 · 2025: 7 · 2024: 3 · 2023: 7 · 2022: 3
FWCI
1.63
Type
journal article
Language
en
Open access
Licence
Locations
  • mSystems (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • HHS | National Institutes of Health (HL134850, HL084207, AI108255)
  • American Heart Association (18EIA33890055)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
nicotinamide riboside, gut microbiota, high-fat diet, weight gain, obesity, metabolic disorders, mitochondrial dysfunction, microbiota transfer, precision medicine
MeSH terms
Gastrointestinal Microbiome, Animals, Diabetes Mellitus, Type 2, Humans, Male, Mice, Inbred C57BL, NAD, Niacinamide, Obesity, Pyridinium Compounds, Vitamins, Weight Gain, Mice, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in Mice. https://app.cochat.ai/papers/10.1128/msystems.00230-21
The paper
Lozada-Fernández, V. V., deLeon, O., Kellogg, S. L., Saravia, F. L., Hadiono, M. A., Atkinson, S. N., Grobe, J. L., & Kirby, J. R. (2022). Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in Mice. mSystems. https://doi.org/10.1128/msystems.00230-21

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.